Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

2.

Renal denervation in the management of resistant hypertension: current evidence and perspectives.

Jin Y, Persu A, Staessen JA.

Curr Opin Nephrol Hypertens. 2013 Sep;22(5):511-8. doi: 10.1097/MNH.0b013e3283640024. Review.

PMID:
23892701
3.

Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry.

Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump LC, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G.

EuroIntervention. 2013 Aug 22;9(4):484-92. doi: 10.4244/EIJV9I4A78.

4.

[Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].

Azpiri-López JR, Assad-Morell JL, Ponce de León-Martínez E, Monreal-Puente R, Dávila-Bortoni A, Vázquez-Díaz LA, Treviño-Frutos RJ, Barrera-Oranday F, Del Angel-Soto JG, Martínez JG, Arellano-Torres M.

Arch Cardiol Mex. 2015 Apr-Jun;85(2):154-7. doi: 10.1016/j.acmx.2014.11.007. Epub 2015 Feb 18. Spanish.

PMID:
25700579
5.

Renal Denervation for Resistant Hypertension: Past, Present, and Future.

Ott C, Schmieder RE.

Curr Hypertens Rep. 2015 Aug;17(8):65. doi: 10.1007/s11906-015-0577-6. Review.

PMID:
26134635
6.

Renal denervation for the treatment of resistant hypertension: review and clinical perspective.

Iliescu R, Lohmeier TE, Tudorancea I, Laffin L, Bakris GL.

Am J Physiol Renal Physiol. 2015 Oct 1;309(7):F583-94. doi: 10.1152/ajprenal.00246.2015. Epub 2015 Jul 29. Review.

7.

Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.

Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA; Symplicity HTN-2 Investigators.

Circulation. 2012 Dec 18;126(25):2976-82. doi: 10.1161/CIRCULATIONAHA.112.130880.

8.

[Renal denervation. Current developments].

Saleh A.

Radiologe. 2013 Mar;53(3):216-22. doi: 10.1007/s00117-012-2419-8. German.

PMID:
23503777
9.

[Percutaneous renal denervation in patients with resistant hypertension--first experiences in Austria].

Goliasch G, Wolzt M, Höfer P, Delle-Karth G, Kreiner G, Neunteufel T, Maurer G, Binder T.

Wien Klin Wochenschr. 2010 Dec;122(23-24):723-6. doi: 10.1007/s00508-010-1486-y. Epub 2010 Nov 12. German.

PMID:
21120701
10.

Renal sympathetic denervation in the aftermath of Symplicity HTN-3.

Kjeldsen SE, Fadl Elmula FE, Persu A, Jin Y, Staessen JA.

Blood Press. 2014 Oct;23(5):256-61. doi: 10.3109/08037051.2014.953861. Review. No abstract available.

PMID:
25212427
11.

Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience.

Simonetti G, Spinelli A, Gandini R, Da Ros V, Gaspari E, Coco I, De Francesco M, Santucci D, Di Daniele N, Lauro R.

Radiol Med. 2012 Apr;117(3):426-44. doi: 10.1007/s11547-011-0766-6. Epub 2012 Jan 7.

PMID:
22228124
12.

Successful treatment of resistant hypertension with percutaneous renal denervation therapy.

Ong PJ, Foo D, Ho HH.

Heart. 2012 Dec;98(23):1754-5. doi: 10.1136/heartjnl-2012-302549. Epub 2012 Jul 21. No abstract available.

PMID:
22821275
13.

[Catheter-based treatment of drug-resistant hypertension].

De Benedetti E.

Rev Med Suisse. 2011 Nov 16;7(317):2242-4. Review. French.

PMID:
22400353
14.

[Renal artery denervation for treating refractory hypertension].

Benamer H, Louvard Y, Garot P, Unterseeh T, Hovasse T, Lefèvre T, Chevalier B, Morice MC.

Ann Cardiol Angeiol (Paris). 2011 Dec;60(6):354-60. doi: 10.1016/j.ancard.2011.09.005. Epub 2011 Oct 14. French.

PMID:
22040858
15.

[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].

Mahfoud F, Vonend O, Bruck H, Clasen W, Eckert S, Frye B, Haller H, Hausberg M, Hoppe UC, Hoyer J, Hahn K, Keller T, Krämer BK, Kreutz R, Potthoff SA, Reinecke H, Schmieder R, Schwenger V, Kintscher U, Böhm M, Rump LC; Arbeitsgemeinschaft Herz und Niere der Deutschen Gesellschaftfür Kardiologie – Herz- und Kreislaufforschunge V und der Deutschen Gesellschaft für Nephrologiee  V sowie der Deutschen Hochdruckliga e V DHL® – DeutscheGesellschaft für Hypertonie und Prävention.

Dtsch Med Wochenschr. 2011 Nov;136(47):2418. doi: 10.1055/s-0031-1272580. Epub 2011 Nov 2. German.

PMID:
22048949
16.

Renal denervation revisited: promising treatment for resistant hypertension?

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2011 Dec;13(12):931-2. doi: 10.1111/j.1751-7176.2011.00563.x. No abstract available.

17.

ESH position paper: renal denervation - an interventional therapy of resistant hypertension.

Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C.

J Hypertens. 2012 May;30(5):837-41. doi: 10.1097/HJH.0b013e328352ce78.

PMID:
22469838
18.

Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.

Geisler BP, Egan BM, Cohen JT, Garner AM, Akehurst RL, Esler MD, Pietzsch JB.

J Am Coll Cardiol. 2012 Oct 2;60(14):1271-7. doi: 10.1016/j.jacc.2012.07.029. Epub 2012 Sep 12.

19.

Hypertension: is the sham procedure 'toxic' for renal denervation?

Tsioufis C.

Nat Rev Nephrol. 2014 Apr;10(4):186-7. doi: 10.1038/nrneph.2014.28. Epub 2014 Mar 4.

PMID:
24595040
20.

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M.

Circulation. 2011 May 10;123(18):1940-6. doi: 10.1161/CIRCULATIONAHA.110.991869. Epub 2011 Apr 25.

Supplemental Content

Support Center